Oberndorfer and his successors: from carcinoid to neuroendocrine carcinoma

Günter Klöppel1

  • 1Department of Pathology, University of Kiel, Michaelisstr. 11, 24105, Kiel, Germany. guenterkloeppel@path.uni-kiel.de

Endocrine Pathology
|October 26, 2007
PubMed

Insights

The historical understanding of carcinoid tumors evolved into neuroendocrine tumors, highlighting their diverse biological behavior and the need for precise classification. Recent advancements include new World Health Organization and tumor-nodes-metastasis classifications for gastroenteropancreatic neuroendocrine neoplasms.

Area of Science:

  • Oncology
  • Endocrinology
  • Pathology

Background:

  • The historical concept of
  • carcinoid tumors
  • originated from Oberndorfer's 1907 description, with their endocrine nature proposed by Masson in 1914.

Discussion:

  • Feyrter and Pearse established the diffuse endocrine cell system concept, proposing a family of cells giving rise to similar tumors.
  • Neuroendocrine tumors are characterized by specific polypeptide expression and common markers like synaptophysin and chromogranin A.

Key Insights:

  • Neuroendocrine neoplasms exhibit significant biological heterogeneity despite histological similarities, impacting treatment strategies.
  • Classifying these tumors based on malignancy risk is crucial for effective patient management.

Outlook:

  • The development of new World Health Organization and tumor-nodes-metastasis classifications for gastroenteropancreatic neuroendocrine tumors aims to refine diagnosis and treatment.
  • Continued research into molecular markers and biological behavior will further improve the stratification of neuroendocrine neoplasms.